We are live on ! Find out more
FBIO icon

Fortress Biotech
FBIO

54 hedge funds and large institutions have $28.8M invested in Fortress Biotech in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 17 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

20% more capital invested

Capital invested by funds: $24M → $28.8M (+$4.8M)

13% more funds holding

Funds holding: 48 → 54 (+6)

0.06% less ownership

Funds ownership: 0.86% → 0.8% (-0.06%)

29% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 17

Holders
54
Holders Change
+6
Holders Change %
+12.5%
% of All Funds
1.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
12
Reduced
17
Closed
4
Calls
$98K
Puts
–
Net Calls
+$98K
Net Calls Change
+$18K

Top Buyers

Rank Fund Capital Flow
1
AHB
Abner Herrman & Brock
New Jersey
+$409K
2
BlackRock
BlackRock
New York
+$385K
3
State Street
State Street
Massachusetts
+$237K
4
Renaissance Technologies
Renaissance Technologies
New York
+$168K
5
Deutsche Bank
Deutsche Bank
Germany
+$163K

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$1.55M
2
Millennium Management
Millennium Management
New York
-$739K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$419K
4
VKH
Virtu KCG Holdings
New York
-$188K
5
CAM
ClariVest Asset Management
California
-$168K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
26
American International Group
New York
$97K -$2.24K -38 -3%
NFA
27
Nationwide Fund Advisors
Ohio
$97K – – –
VOYA Investment Management
28
VOYA Investment Management
Georgia
$89K +$73.5K +1,244 New
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$84K +$32.3K +547 +87%
BMCM
30
Bryn Mawr Capital Management
Pennsylvania
$68K +$56K +948 New
LCM
31
Landscape Capital Management
New Jersey
$67K – – –
Invesco
32
Invesco
Georgia
$64K +$53.3K +903 New
GC
33
Guggenheim Capital
Illinois
$53K -$413 -7 -0.9%
Millennium Management
34
Millennium Management
New York
$52K -$739K -12,509 -95%
HAG
35
HighPoint Advisor Group
Illinois
$51K – – –
Manulife (Manufacturers Life Insurance)
36
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$38K +$413 +7 +1%
Bank of America
37
Bank of America
North Carolina
$32K -$1.12K -19 -4%
Creative Planning
38
Creative Planning
Kansas
$29K – – –
CG
39
Cutler Group
California
$26K -$42.2K -714 -66%
DAM
40
Delta Asset Management
Tennessee
$24K – – –
Legal & General Group
41
Legal & General Group
United Kingdom
$20K – – –
BNP Paribas Financial Markets
42
BNP Paribas Financial Markets
France
$17.7K +$13.8K +234 +1,671%
UBS Group
43
UBS Group
Switzerland
$15K -$159K -2,685 -93%
AIP
44
Ameritas Investment Partners
Nebraska
$13K – – –
PAM
45
Panagora Asset Management
Massachusetts
$10K +$8.03K +136 New
AIM
46
Acrospire Investment Management
Illinois
$10K +$8.21K +139 New
Federated Hermes
47
Federated Hermes
Pennsylvania
$9K +$7.2K +122 New
MAM
48
Meeder Asset Management
Ohio
$4K – – –
Bank of Montreal
49
Bank of Montreal
Ontario, Canada
$3K – – –
FANJ
50
Financial Architects (New Jersey)
New Jersey
$2K – – –
1
2
3

FBIO Hedge Fund Activity: Q2 2017 in Review

54 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q2 2017, worth a combined $28.8M — up 20% from $24M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new FBIO positions and 4 closed out — a net gain of 6 holders — while 12 added to existing stakes and 17 trimmed.

The largest buyer was Abner Herrman & Brock, opening a new position worth an estimated $409K. The largest seller was Avoro Capital Advisors, cutting an estimated $1.55M.

  • 54 institutional investors held Fortress Biotech (FBIO) as of Q2 2017, up from 48 in Q1 2017.
  • Funds reported $28.8M of Fortress Biotech stock for Q2 2017, up 20% quarter-over-quarter.
  • 10 funds opened new Fortress Biotech positions in Q2 2017 and 4 closed out, a net change of +6 holders.
  • The largest Fortress Biotech buyer in Q2 2017 was Abner Herrman & Brock, an estimated $409K added.
  • The largest Fortress Biotech seller in Q2 2017 was Avoro Capital Advisors, an estimated $1.55M sold.

Based on aggregated 13F filings for Q2 2017.